Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists

被引:5
|
作者
Zhou, Ya-Ju
Zhu, Li-Ping
Tang, Yun
Ye, De-Yong
机构
[1] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
[2] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 200032, Peoples R China
关键词
structure-based; 3D-QSAR; CoMFA; CoMSIA; 5-HT3; receptor;
D O I
10.1016/j.ejmech.2006.12.029
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-based 3D-QSAR studies were perfortned on a series of novel heteroarylpiperazine derivatives as 5-HT3 receptor antagonists with comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) methods. The compounds were initially docked into the binding pocket of the homology model of 5-HT3 receptor using GOLD program. The docked conformations with the highest score were then extracted and used to build the 3D-QSAR models, with cross-validated 1-2 values 0.716 and 0.762 for CoMFA and CV CoMSIA, respectively. The CoMFA and CoMSIA contour plots were also fitted into the 3D structural model of the receptor to identify the key interactions between them, which might be helpful for designing new potent 5-HT3 receptor antagonists. (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
下载
收藏
页码:977 / 984
页数:8
相关论文
共 50 条
  • [41] Spectrum of use and tolerability of 5-HT3 receptor antagonists
    Haus, U
    Späth, M
    Färber, L
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 : 12 - 18
  • [42] Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists
    Wolf, H
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2000, 29 : 37 - 45
  • [43] 5-HT3 receptor antagonists for the treatment of nausea/vomiting
    Smith, Howard S.
    Cox, Lorraine R.
    Smith, Eric J.
    ANNALS OF PALLIATIVE MEDICINE, 2012, 1 (02) : 115 - 120
  • [44] THE ECONOMIC-IMPACT OF 5-HT3 RECEPTOR ANTAGONISTS
    CUNNINGHAM, K
    HIRSCH, J
    FREEMAN, A
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (06) : 930 - 930
  • [45] Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
    Eisensamer, B
    Rammes, G
    Gimpl, G
    Shapa, M
    Ferrari, U
    Hapfelmeier, G
    Bondy, B
    Parsons, C
    Gilling, K
    Zieglgänsberger, W
    Holsboer, F
    Rupprecht, R
    MOLECULAR PSYCHIATRY, 2003, 8 (12) : 994 - 1007
  • [46] Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
    Eisensamer, B
    Rammes, G
    Gimpl, G
    Shapa, M
    Ferrari, U
    Hapfelmeier, G
    Bondy, B
    Parsons, C
    Gilling, K
    Zieglgänsberger, W
    Holsboer, F
    Rupprecht, R
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 223 - 223
  • [47] Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
    B Eisensamer
    G Rammes
    G Gimpl
    M Shapa
    U Ferrari
    G Hapfelmeier
    B Bondy
    C Parsons
    K Gilling
    W Zieglgänsberger
    F Holsboer
    R Rupprecht
    Molecular Psychiatry, 2003, 8 : 994 - 1007
  • [48] 3D-QSAR analyses of melatonin antagonists
    Zhu, LL
    Xu, XJ
    ACTA PHYSICO-CHIMICA SINICA, 2002, 18 (12) : 1087 - 1092
  • [49] 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method
    Pourbasheer, E.
    Tabar, S. Shokouhi
    Masand, V. H.
    Aalizadeh, R.
    Ganjali, M. R.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2015, 26 (06) : 461 - 477
  • [50] 3D-QSAR and docking studies on transforming growth factor (TGF)-β receptor 1 antagonists
    Geldenhuys, Werner J.
    Nakamura, Hiroshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (06) : 1918 - 1923